Provided by Tiger Trade Technology Pte. Ltd.

Merck

147.76
-0.5900-0.40%
Post-market: 148.470.7090+0.48%19:58 EDT
Volume:11.13M
Turnover:1.64B
Market Cap:364.55B
PE:116.09
High:148.69
Open:147.00
Low:145.95
Close:148.35
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.03
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.25%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.69
PE(LYR):20.30

Loading ...

FDA: Approves Pembrolizumab or Pembrolizumab and Berahyaluronidase Alfa-pmph Each with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer

THOMSON REUTERS
·
Jul 10

Berenberg Adjusts Price Target on Merck to $127 From $125, Keeps Hold Rating

MT Newswires Live
·
Jul 10

Merck & Co Inc : Berenberg Raises Target Price to $127 from $125

THOMSON REUTERS
·
Jul 10

Merck is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 10

Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK)

TIPRANKS
·
Jul 09

China's Sinopharm Held Strategic Cooperation Talks with Msd in Shanghai - Company Statement

THOMSON REUTERS
·
Jul 09

GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad

TIPRANKS
·
Jul 09

Merck Likely to Post Inline Q2 Revenue, RBC Says

MT Newswires Live
·
Jul 08

Merck Price Target Maintained with a $142.00/share by RBC Capital

Dow Jones
·
Jul 08

Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026

GlobeNewswire
·
Jul 08

Merck & Co Inc:

THOMSON REUTERS
·
Jul 08

Merck: Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations

THOMSON REUTERS
·
Jul 08

Former Merck and NASA Leaders Bring Strategic Expertise to Spacemd Amid Rising Demand for Its In-space Pharmaceutical Development Capabilities

THOMSON REUTERS
·
Jul 08

Merck is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jul 08

Wells Fargo Adjusts Price Target on Merck to $150 From $145

MT Newswires Live
·
Jul 08

Race to Launch Weight-loss Pills Heats up as Smaller Players Advance

Reuters
·
Jul 08

Merck & Co. Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 07

Merck price target raised to $150 from $135 at HSBC

TIPRANKS
·
Jul 06

Merck Price Target Maintained with a $120.00/share by Cantor Fitzgerald

Dow Jones
·
Jul 06

Top of the Street: Pharma, Socgen, Antofagasta, Wise, Castellum

Reuters
·
Jul 06